BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28185859)

  • 1. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
    Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
    Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
    Hammad A; Mossad YM; Nasef N; Eid R
    Lupus; 2017 Jul; 26(8):871-880. PubMed ID: 28059021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The
    Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
    Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
    Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
    Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
    Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
    Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.
    Tang L; Wan P; Wang Y; Pan J; Wang Y; Chen B
    Inflamm Res; 2015 Oct; 64(10):817-24. PubMed ID: 26294277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus.
    Cherian TS; Kariuki SN; Franek BS; Buyon JP; Clancy RM; Niewold TB
    Arthritis Rheum; 2012 Oct; 64(10):3383-7. PubMed ID: 22674082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.
    Feng D; Stone RC; Eloranta ML; Sangster-Guity N; Nordmark G; Sigurdsson S; Wang C; Alm G; Syvänen AC; Rönnblom L; Barnes BJ
    Arthritis Rheum; 2010 Feb; 62(2):562-73. PubMed ID: 20112383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of IRF5 polymorphisms with activation of the interferon alpha pathway.
    Rullo OJ; Woo JM; Wu H; Hoftman AD; Maranian P; Brahn BA; McCurdy D; Cantor RM; Tsao BP
    Ann Rheum Dis; 2010 Mar; 69(3):611-7. PubMed ID: 19854706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus.
    Hu W; Ren H
    Int J Immunogenet; 2011 Oct; 38(5):411-7. PubMed ID: 21834935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms.
    Kawasaki A; Kyogoku C; Ohashi J; Miyashita R; Hikami K; Kusaoi M; Tokunaga K; Takasaki Y; Hashimoto H; Behrens TW; Tsuchiya N
    Arthritis Rheum; 2008 Mar; 58(3):826-34. PubMed ID: 18311811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.
    Miceli-Richard C; Comets E; Loiseau P; Puechal X; Hachulla E; Mariette X
    Arthritis Rheum; 2007 Dec; 56(12):3989-94. PubMed ID: 18050197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.
    Hellquist A; Järvinen TM; Koskenmies S; Zucchelli M; Orsmark-Pietras C; Berglind L; Panelius J; Hasan T; Julkunen H; D'Amato M; Saarialho-Kere U; Kere J
    J Rheumatol; 2009 Aug; 36(8):1631-8. PubMed ID: 19567624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
    Ferreiro-Neira I; Calaza M; Alonso-Perez E; Marchini M; Scorza R; Sebastiani GD; Blanco FJ; Rego I; Pullmann R; Pullmann R; Kallenberg CG; Bijl M; Skopouli FN; Mavromati M; Migliaresi S; Barizzone N; Ruzickova S; Dostal C; Schmidt RE; Witte T; Papasteriades C; Kappou-Rigatou I; Endreffy E; Kovacs A; Ordi-Ros J; Balada E; Carreira P; Gomez-Reino JJ; Gonzalez A
    Genes Immun; 2007 Jul; 8(5):429-38. PubMed ID: 17568788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.